આજે જાહેર થનારા કંપની પરીણામઃ ભારત ફોર્જ, ડિવિઝ લેબ, એક્સાઇડ ઇન્ડસ્ટ્રીઝ, ઝાયડસ વેલનેસ, ટીબીઝેડ

અમદાવાદ, 6 નવેમ્બરઃ ભારત ફોર્જ, ડિવિઝ લેબ, એક્સાઇડ ઇન્ડસ્ટ્રીઝ, ઝાયડસ વેલનેસ, ટીબીઝેડ સહિત સંખ્યાબંધ કંપનીઓ આજે Q2FY24 EARNING જાહેર કરશે.અગ્રણી બ્રોકરેજ હાઉસ અને માર્કેટ નિષ્ણાતો દ્વારા રજૂ કરાયેલા અંદાજો અને એનાલિસિસ આ સાથે પ્રસ્તુત કર્યા છે. જેના આધારે રોકાણકારો સ્ટોક સ્પેસિફિક અભ્યાસના આધારે ટ્રેડિંગ સ્ટ્રેટેજી ઘડી શકે છે.

 Q2FY24 EARNING CALENDAR 06.11.2023: ADANIENSOL, AIAENG, BAJAJELEC, BANCOINDIA, BARBEQUE, BHARATFORG, BIKAJI, BLS, BORORENEW, CAMLINFINE, DALMIASUG, DIVISLAB, EMAMILTD, EXIDEIND, GATEWAY, GIPCL, GLAND, GREENPLY, GSPL, HEIDELBERG, HGINFRA, HINDPETRO, HONAUT, ICIL, IPL, JAMNAAUTO, KOLTEPATIL, KPRMILL, LIBERTSHOE, LINDEINDIA, MANINFRA, MAXHEALTH, MONTECARLO, NHPC, NYKAA, ONMOBILE, PARAS, PGEL, POWERINDIA, RADICO, REDINGTON, ROSSELLIND, RRKABEL, RUPA, SEQUENT, SNOWMAN, SOBHA, SPARC, SUNDARAM, TBZ, UJJIVAN, UTTAMSUGAR, VALIANTLAB, VBL, VMART, WABAG, ZYDUSWELL

BHARATFORG

Revenue expected at Rs 3964 crore versus Rs 3076 crore

EBITDA expected to be seen at Rs 625 crore versus Rs 435 crore

EBITDA margin expected to be seen at 15.8% versus 14.1%

Net profit expected to be seen at Rs 288 crore versus of Rs 145 crore

DIVISLAB

Revenue expected at Rs 1929 crore versus Rs 1854 crore

EBITDA expected to be seen at Rs 587 crore versus Rs 621 crore

EBITDA margin expected to be seen at 30.4% versus 33.4%

Net profit expected to be seen at Rs 441 crore versus of Rs 493 crore

EXIDEIND

Revenue expected at Rs 4050 crore versus Rs 3718 crore

EBITDA expected to be seen at Rs 449 crore versus Rs 412 crore

EBITDA margin expected to be seen at 11.1% versus 11.1%

Net profit expected to be seen at Rs 258 crore versus of Rs 246 crore

HONAUT

Revenue expected at Rs 947 crore versus Rs 794 crore

EBITDA expected to be seen at Rs 146 crore versus Rs 127 crore

EBITDA margin expected to be seen at 15.4% versus 16.1%

Net profit expected to be seen at Rs 123 crore versus of Rs 117 crore

MAXHEALTH

Revenue expected at Rs 1702 crore versus Rs 1137 crore

EBITDA expected to be seen at Rs 462 crore versus Rs 318 crore

EBITDA margin expected to be seen at 27.1% versus 28.0%

Net profit expected to be seen at Rs 314 crore versus of Rs 457 crore

NHPC

Revenue expected at Rs 3269 crore versus Rs 3366 crore

EBITDA expected to be seen at Rs 2068 crore versus Rs 2187 crore

EBITDA margin expected to be seen at 63.2% versus 64.9%

Net profit expected to be seen at Rs 1573 crore versus of Rs 1433 crore

RADICO

Revenue expected at Rs 920 crore versus Rs 3018 crore

EBITDA expected to be seen at Rs 121 crore versus Rs 90 crore

EBITDA margin expected to be seen at 13.1% versus 2.98%

Net profit expected to be seen at Rs 59 crore versus of Rs 54 crore

ZYDUSWELL

Revenue expected at Rs 461 crore versus Rs 429 crore

EBITDA expected to be seen at Rs 28 crore versus Rs 16 crore

EBITDA margin expected to be seen at 6.07% versus 3.78%

Net profit expected to be seen at Rs 18 crore versus of Rs 8.4 crore

Q2FY24 EARNING CALENDAR 07.11.2023: AARTIPHARM, ALKEM, ALKYLAMINE, ANURAS, APLLTD, APOLLOTYRE, ARVINDFASN, ATULAUTO, AVANTI, BALMLAWRIE, BALRAMCHIN, CARYSIL, COCHINSHIP, CRISIL, CUMMINSIND, DBL, DBREALTY, DEEPAKNI, DEVYANI, DOLLAR, EVEREADY, GHCL, GREAVESCOT, GSFC, HARSHA, HAWKINCOOK, HESTERBIO, HIMATSEIDE, IDEAFORGE, IRCTC, ITDC, JYOTHYLAB, KIRLOSBROS, KOPRAN, LIKHITHA, LUMAXIND, LUXIND, MAFATIND, MANALIPETC, MIDHANI, NAUKRI, NEULANDLAB, POWERGRID, PRAKASH, PRESTIGE, PRINCEPIPE, RAIN, ROLEXRINGS, SAINTGOBAIN, SALASAR, SANGHVIMOV, SCHNEIDER, SHREECEM, SJS, SKIPPER, STOVEKRAFT, TRENT, UDS, UNOMINDA, VARROC, VIJAYA, VSSL, VSTTILLERS, YATHARTH, ZAGGLE, ZYDUSLIFE

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)